SummitMD

--Thursday, April 28
-	Drug Eluting Stent Summit-I
-	New Clinical Trials Updates 2005 - from TCT, AHA, ACC
-	The Future of DES and Complex PCI
-	Virtual Histology; Beyond IVUS
-	"ENDEAVOR"- What's New ? What's Different ?
-	Is Cypher the Best Choice? - Clinical Perspectives of Cypher
--Friday, April 29
-	Plenary Sessions
-	Vulnerable Plaque
-	Bifurcation Lesions
-	Drug Eluting Stent Summit - II
-	Acute Myocardial Infarction
-	Chronic Total Occlusions
-	Complex PCI
-	Angiomygenesis
-	Current Standards and Proposed Directions in Pharmacologic Approaches for PCI
-	Lipid Management : A New Era in The Treatment of Coronary Artery Disease
-	Drug Eluting Stent Summit - III
-	"Reducing Cardiovascular Risk" Keyword in Managing Hypertension and Lipid
--Saturday, April 30
-	Plenary Sessions
-	EuroPCR Session
-	Left Main Lesions
-	Drug Eluting Stent Summit - IV
-	Management of Complications
-	IVUS, OCT, Thrombectomy, Atherectomy, and Cutting
-	Peripheral Lesions
-	Why not TRI ?
-	Promise of Glitazone
-	Advanced Endovascular Therapy: Cordis Clinical Results on Renal and SFA Stenting

Drug Eluting Stent Summit-I

•	DES Pathobiology Considerations: What We Know and What We Don't Know Can Hurt Us!
	-Presenter : Renu Virmani, MD

•	Late Loss Remains the Best Single Indicator of DES Performance
	-Presenter : Richard E. Kuntz , MD

•	Is the TAXUS Stent Benefit Extended to the Most Complicated Patients and Lesions?
	-Presenter : Eberhard Grube, MD

•	New Drug Eluting Stents
	-Presenter : Alexandre Abizaid, MD

•	Are All Sirolimus Analogs Alike?
	-Presenter : Robert Falotico, MD

•	Paclitaxel-Eluting TAXUS Stents Strengths and Weaknesses
	- Presenter : Gregg W. Stone, MD

•	The "Appropriate" Use of IVUS During DES Procedures
	- Presenter : Gary S. Mintz, MD

Drug Eluting Stent Summit-II

•	DES for Bifurcation Lesion
	- Presenter: Yean-Teng Lim, MD

•	DES for Complex Patients Subsets
	- Presenter: Alexandre Abizaid, MD

•	Everolimus Drug-Eluting Stents I: Review of Guidant FUTURE I and II, and Status Update of FUTURE III and IV
	- Presenter: Eberhard Grube, MD

•	ZoMaxx: Abbott's Drug Eluting Stent Program
	- Presenter: John Ormiston, MD

Drug Eluting Stent Summit-III

•	Drug-Eluting Biodegradable Igaki-Tamai Stent
	- Presenter: Hideo Tamai, MD

•	Update on the Endeavor I-V Trials: The Latest Results
	- Presenter: Ian T. Meredith, MD

•	Terumo DES Program -Nobori 1 Clinical Trial
	- Presenter: Hidehiko Honda, MD

•	Update on Jupiter l and ll Clinical Trials with the Sorin Carbostent Tacrocimus Eluting Stent
	- Presenter: Gian Battista Danzi, MD

Drug Eluting Stent Summit-IV

•	ABT 578 Drug-Eluting Stents II: Preclinical Observations and the Clinical Trial Strategy for the Abbott ZoMax Stent
	- Presenter: Alan C. Yeung, MD

•	Reopro Eluting Stents in Acute Coronary Syndrome
	- Presenter: Myung-Ho Jeong, MD

•	Cypher PK study in Japan
	- Presenter: Masato Nakamura, MD

New Clinical Trials Updates 2005 - from TCT, AHA, ACC

•	The Biolimus A9 DES Program (Focus on Stealth 1)
	-Presenter : Eberhard Grube , MD

•	The Endeavor DES Program (Focus on Endeavor 2)
	-Presenter : Richard E. Kuntz, MD

•	Recent Updates from the Cypher Trials (Cypher Meta-Analysis, Diabetes, Late FU from FIM and SIRIUS, ARTS II)
	-Presenter : Alexandre Abizaid , MD

•	Recent Updates from the Taxus Trials (Taxus 2 and 4 Late FU, Taxus Meta-Analysis, and Taxus 5)
	-Presenter : Gregg W. Stone, MD

The Future of DES and Complex PCI

•	Taxus V Clinical Update
	-Presenter : Gregg W. Stone, MD

•	Diabetic Performance in Taxus
	-Presenter : Myung-Ho Jeong, MD

•	IVUS in Complex PCI
	-Presenter : Alan C. Yeung, MD

•	Pre & Post-Dilatation Strategies for DES
	-Presenter : Ted Feldman, MD

Virtual Histology; Beyond IVUS

•	Virtual History: Concept and Validation
	-Presenter : D. Geoffrey Vince, MD

•	Virtual Histology- A Technical & Clinical Update
	-Presenter : Gary S. Mintz, MD

•	Real World Paradigm for Identifying Vulnerable Plaques and Vulnerable Patients
	-Presenter : James R. Margolis, MD

"ENDEAVOR"- What's New ? What's Different ?

•	Overview of Endeavor II Clinical Results
	-Presenter : Ian T. Meredith, MD

•	Safety and Endeavor II Subsets
	-Presenter : Richard E. Kuntz, MD

Is Cypher the Best Choice? - Clinical Perspectives of Cypher

•	REALITY Head-To-Head Comparison
	-Presenter : Alexandre Abizaid, MD

•	Safety and Efficacy of Cypher on Complex Lesion
	-Presenter : Seung-Jung Park, MD

•	Is Sirolimus Different from Analogues?
	-Presenter : Robert Falotico, MD

Plenary Sessions

•	The E-valve Edge-to-Edge Repair for Mitral Regurgitation: Design Concept and EVEREST Update
	-Presenter : Ted Feldman, MD

•	New Concept and Device for Ostial and Bifurcation Stenting
	-Presenter : Yaron Almagor, MD

•	Percutaneous Interventions for Patent Foramen Ovale
	-Presenter : Eric Eeckhout, MD

•	Evidence-Based Medicine Analysis of Current DES Clinical Use Guidelines: A Roadmap for Clinicians
	-Presenter : Gregg W. Stone, MD

•	Plaque Progression and Regression
	-Presenter : James R. Margolis, MD

•	What Are the Proper End Points for DES Trials?
	-Presenter : Alan C. Yeung, MD

•	Drug-Eluting Stents, Late Loss, and Restenosis DES to Prevent MIs
	-Presenter : Richard E. Kuntz, MD

•	Peripheral Vascular Interventions: What Is Possible in 2005 ?
	-Presenter : Gerald Dorros, MD

•	Renal Stenting: ASPIRE II , Update on Resist and CORAL Trial Status
	-Presenter : Krishna Rocha-Singh, MD

•	SFA Interventions (Including New Technique, CTO)
	-Presenter : Krishna Rocha-Singh, MD

•	Virtual Histology - A Technical and Clinical Update
	-Presenter : Gary S. Mintz, MD

•	Pathology of Vulnerable Plaque
	-Presenter : Renu Virmani, MD

Vulnerable Plaque

•	Erosion, Intraplaque Hemorrhage: The Other Face of Vulnerability
	-Presenter : Renu Virmani, MD

•	Characterization of Coronary Atherosclerotic Plaques Using CTA
	-Presenter : Koen Nieman, MD

•	Coronary Artery Thermography
	-Presenter : Christodoulos Stefanadis, MD

•	Detection and Treatment of Thin Fibrous Cap, Lipid Rich, and Inflammatory Vulnerable Plaque - Angioscopic Evaluation
	-Presenter : Kyoichi Mizuno, MD

•	Epidemiologic Stent-Based Approach to Vulnerable Plaque Stabilization Based on Statistical Modeling of Plaque Rupture and Death
	-Presenter : Richard E. Kuntz, MD

•	Regional Photodynamic Therapy for Vulnerable Plaque Stabilization I: Antrin
	-Presenter : Alan C. Yeung, MD

Bifurcation Lesions

•	Bench Insights into Bifurcation Stenting Strategies. An Update
	- Presenter: John Ormiston, MD

•	Efficacy of FX Minirail Balloon in Bifurcation Lesions
	Presenter: Junbo Ge, MD

Acute Myocardial Infarction

•	EMERALD Trial: Lessons Learned
	- Presenter: Gregg W. Stone, MD

•	Final Results of ASPARAGAS Study
	- Presenter: Toshiya Muramatsu, MD

•	Coronary Flow Pattern and Myocardial Viability: Comparison with PET
	- Presenter: Seung-Jea Tahk, MD

•	Multivessel versus Single-vessel Angioplasty During Acute MI
	- Presenter: Mun Kyung Hong, MD

Chronic Total Occlusions

•	Coated vs Non-Coated Wires for CTO
	- Presenter: James R. Margolis, MD

•	Long Term Outcome of 1,000 CTO Cases
	- Presenter: Toshiya Muramatsu, MD

•	Zen Philosophy - The KEY to CTO Success
	- Presenter: Gregg W. Stone, MD

Complex PCI

•	Drug Eluting Stents in CTO
	- Presenter: Kenneth Chin, MD

•	Cypher - LAD Ostial Lesions; No More Surgery !
	- Presenter: Ki Bae Seung, MD

Angiomygenesis

•	Angiogenesis Mediated by Adipose-Derived Stromal Cells: How Fat Can Be Good
	- Presenter: Keith L. March, MD

Current Standards and Proposed Directions in Pharmacologic Approaches for PCI

•	Optimizing Outcomes of Primary PCI: From CADILLAC to HORIZONS
	- Presenter: Gregg W. Stone , MD

Lipid Management : A New Era in The Treatment of Coronary Artery Disease

•	The TNT Trial: Is It Time to Shift Our Goals in Clinical Practice
	- Presenter: David Colquhoun, MD

•	Early Statin Therapy in Acute Coronary Syndrome
	- Presenter: Cheol-Whan Lee, MD

•	Beyond the Statin Therapy: The Importance of HDL Cholesterol
	- Presenter: Ki Hoon Han, MD

"Reducing Cardiovascular Risk" Keyword in Managing Hypertension and Lipid

•	Mechanisms Linking Angiotensin II & Atherogenesis
	- Presenter: Carlos M. Ferrario, MD

EuroPCR Session

•	Lesson Learnt During Live Cases Transmission at EuroPCR 2004
	- Presenter: Jean Fajadet, MD

•	The Future Role of the Cardiologist in Extracardiac Intervention
	- Presenter: Giancarlo Biamino, MD

•	Clinical Relevance of Stent Fractures in the Treatment of SFA Lesion
	- Presenter: Giancarlo Biamino, MD

•	Lesson Learnt in the Complication Session at EuroPCR 2004
	- Presenter: Eric Eeckhout, MD

Left Main Lesions

•	Medium Term Follow-up of Drug-Eluting Stents in Left Main Bifurcation Stenosis
	- Presenter: Teguh Santoso, MD

•	Management of Non-Protected Left Main Bifurcation Without DES
	- Presenter: Masahiko Ochiai, MD

•	LM stenting -Cypher
	- Presenter: Seung-Jung Park, MD

•	LM stenting -TAXUS
	- Presenter: Marc Silvestri, MD

Management of Complications

•	Treatment for No Reflow
	- Presenter: Mark Simmonds, MD

•	Coronary Artery Perforations
	- Presenter: James R. Margolis, MD

•	Transcatheter Closure of Post Acute Myocardial Infarction Ventricular Septal Rupture: Issues and Controversies
	- Presenter: Ajit Sankardas Mullasari, MD

IVUS, OCT, Thrombectomy, Atherectomy, and Cutting

•	IVUS Guide PCI at Acute Coronary Syndrome
	- Presenter: Motomaru Masutani, MD

•	Arterial Plaque Evaluation Using OCT: A Comparison with IVUS and Histological Findings
	- Presenter: Takashi Akasaka, MD

•	The Role of Atherectomy Devices in the Real DES Era
	- Presenter: Etsuo Tsuchikane, MD

Peripheral Lesions

•	Trans-Radial Approach Renal Stenting
	- Presenter: Chiung-Jen Wu, MD

•	The Upsurge in Renal Revascularization: Cosmetic or Clinically Relevant?
	- Presenter: Giancarlo Biamino, MD

•	Carotid Angioplasty is the treatment of Choice for Obstructive Carotid Bifurcation Disease
	- Presenter: Gerald Dorros, MD

Why not TRI

•	TRI for Complex Lesion
	- Presenter: Motomaru Masutani, MD

•	Results of Radial Artery Intervention in >11,000 Patients: A 10-Year Experience
	- Presenter: Jean Fajadet, MD

•	Trans-Radial Intervention for Chronic Total Occlusion
	- Presenter: Takaaki Shiono, MD

•	Changes in the Diameter of the Radial Artery After TRA or TRI
	- Presenter: Yoshifumi Kan, MD

•	Why not TRI in Acute Coronary Syndrome
	- Presenter: Junghan Yoon, MD

•	TRI for Acute Myocardial Infarction in Kyoto, Report from the Registration of Kyoto AMI Conference
	- Presenter: Takashi Okada, MD

Promise of Glitazone

•	Inflammation: Novel Target for Cardiovascular Risk Reduction
	- Presenter: Andrew Zalewski, MD

•	The Promise of the Thiazolidinediones in the Management of Type 2 Diabetes-Associated Cardiovascular Disease
	- Presenter: Stephen Alistair Smith, MD

•	Preventative Effects of Rosiglitazone on Restenosis after Coronary Stent Implantation
	- Presenter: Dong Hoon Choi, MD

Advanced Endovascular Therapy: Cordis Clinical Results on Renal and
SFA Stenting

•	Asian Perspective-Takayasu Disease and Renal Stenting
	- Presenter: Mohd Ali Rosli, MD

•	SFA Stenting: BLASTER Study
	- Presenter: Krishna Rocha-Singh, MD